Ampel

AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.

Business Model:

Revenue: $14M

Employees: 51-200

Rankings

Detailed Ampel Information

Geographic Data

Ampel headquarters map

Address: 250 West Main Street Ste 300

City: Charlottesville

State: VA

Zip: 22902

Country: US

Financial Info

Stage:

debt financing

Raised Last:

$1M

Raised Total:

$1M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

AMPEL BioSolutions is a precision medicine company with a pipeline of CLIA-certified gene expression tests for blood or tissue samples that provides decision support by determining disease status, identifying molecular pathways, and predicting drug options. Genomic platforms, bioinformatics, RNA analytics, and ML/AI algorithms are covered by patents and are disease-agnostic. AMPEL BioSolutions was founded to bring personalized precision medicine to patients with immune system and inflammation diseases. In 2022, AMPEL expects to commercialize its first product, a CLIA-certified blood test for lupus patients/physicians called LuGENE that assesses disease state/flares and best drug option(s). AMPEL&s;s technology covers over 95% of all known genes and is disease agnostic so there is capacity to expand reporting of results into new disease indications without developing a new test. AMPEL&s;s exclusive curated database of &g;10,000 Lupus patient gene expression profiles with rich clinical information is the world&s;s largest and fuels machine learning predictions based on evidence. AMPEL&s;s customers are Pharma/Biotech, utilizing its proprietary genomic platform, bioinformatic tools, and ML/AI algorithms for clinical trial design, management, and patient stratification.

Contact Phone:
+14342962675

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2021 Pre Seed Round $1M
11/2022 Debt $1.1M
12/2022 Debt Financing $1.1M
1/2021 Convertible Note $2.1M
1/2019 Grant $3.1M
3/2020 Pre Seed Round 1 $2.8M U.S. Small Business Administration
U.S. Small Business Administration
3/2021 Convertible Note $2.4M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research